AM-IA brings together news, research papers and applications relating to artificial intelligence published around the world into a single feed — and makes them available in your European language at the click of a button.
Scroll to browse · Click to filter
The system allows some manufacturers to market their products in real conditions before full approval, in exchange for close supervision by the agency.
Out of 1,602 patients and then 541 in external validation, fed models of simple clinical data exceed 0.80 AUROC to distinguish which will decline rapidly within three to five years.
OpenAI opens a read-only gateway between its health assistant and Epic's electronic medical record, so that caregivers can query their patients' data.
At Adventist Health, machine learning had reported opioid diversions from a temporary nurse. Alerts went unanswered.
117 assets designed with AI have entered interventional trials at 63 companies, 60 have completed a phase I and eight a phase II. The capital has exceeded $60 billion since 2019.
Ezekiel Emanuel and Neal Khosla argue that autonomous AI will eventually surpass any doctor-machine tandem, and that regulations should not freeze the requirement for human oversight.
A team from the University of California, San Diego, trained a model on 500,000 variant sequences to characterize the initiator, the element that triggers the reading of a gene.
Michael Polansky's start-up spins a closed loop between prediction by IA and validation on skin tissue from plastic surgery, with six active candidates in development.
Researchers at Arizona State University measured antibodies against 185 antigens in more than 4,000 people to identify a signature of "immune readiness."
Merck and Moderna announce that their individualized neoantigenic vaccine, combined with Keytruda, significantly delays the recurrence of operated melanoma. This is a first for this approach.
For this startup, AI will not cure cancer as long as it learns from static snapshots. Its robotic laboratories produce causal data on living human tissue.
In Nature Chemical Biology, three researchers describe how agentic systems, coupled with benchtop automation, close the design-synthesize-test-analyze loop.
Published in Nature Medicine on Aug. 19, a prospective trial on 10,333 patients ran a liver sensing model alongside radiologists, in the hospital's actual workflow.
In STAT, Arya Rao and Marc Succi argue that announcements about AI that goes beyond doctors have mainly fed private medicine outside the walls, backed by commercial interests.
Security, model reliability, and human interaction: a review published on August 19 proposes a unique framework and recommends dedicated AI security operations centers.
Presented at Epic's annual user conference, the platform is based on a base of 120 AI capabilities already deployed in its electronic patient record.
Anthropic launched its models on fifteen therapeutic targets and had the results tested in a wet laboratory. The success rates obtained are well above the usual range in the industry.
Radiology in the lead with 76% of authorisations, massive hospital adoption: clinical evaluation is struggling to keep pace with market launches.
The Connecticut hospital system is expanding one of the largest clinically supervised, clinically supervised deployments of patient-facing AI in North America.
The ARISE network, backed by Stanford and Harvard, has published its first annual synthesis of clinical AI: clear progress in reasoning, but evaluation and integration into care remain the weak points.